Spasticity alleviation by drugs acting directly on skeletal muscle.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000818:Animals; D002082:Butylamines / Q000494:pharmacology / Q000627:therapeutic use; D004558:Electric Stimulation; D004983:Ethanolamines / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007273:Injections, Intramuscular; D007866:Leg; D008297:Male; D009921:Metaproterenol / Q000008:administration & dosage / Q000627:therapeutic use*; D009119:Muscle Contraction / Q000187:drug effects; D009120:Muscle Cramp / Q000188:drug therapy*; D009128:Muscle Spasticity / Q000188:drug therapy*; D009129:Muscle Tonus / Q000187:drug effects; D009132:Muscles / Q000187:drug effects*; D010627:Phenethylamines / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D000318:Adrenergic beta-Agonists; D002082:Butylamines; D004983:Ethanolamines; D010627:Phenethylamines; D009921:Metaproterenol